Telomir Pharmaceuticals, Inc. Common StockTELONASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-12.24M
↓ 185% below average
Average (3y)
$-4.29M
Historical baseline
Range
High:$-138131.00
Low:$-12.24M
CAGR
+345.9%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-12.24M | -210.6% |
| 2023 | $-3.94M | -361.5% |
| 2022 | $-854147.00 | -518.4% |
| 2021 | $-138131.00 | - |